Increasing Availability Of Advanced Clotting Facto..

创建了一篇新文章

10 在

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market | #hemophilia B

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Increasing Availability Of Advanced Clotting Factor Therapies Is Driving Growth In The Hemophilia B Market

Hemophilia B is a rare inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX, leading to prolonged bleeding episodes, spontaneous hemorrhages, and joint damage.

喜欢

评论

分享